Neuroligand binding endophenotypes in blood cells distinguish two subsets of borderline personality disorder patients

Neuroscience Letters

Volumn 462, Issue 2, 2009, Pages 144-146

  Begni, Barbara ^a   Tremolizzo, Lucio ^a,b   Andreoni, Simona ^a   Contri, Margherita ^b   Uccellini, Orlando ^b   Neri, Francesca ^a,b   Ferrarese, Carlo ^a,b  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b SAN GERARDO HOSPITAL   (Italy)

Author keywords

Borderline personality disorder; Childhood Depression Inventory; Ligand binding; PBMC; Peripheral benzodiazepine receptors; Platelets

Indexed keywords

BENZODIAZEPINE RECEPTOR; SEROTONIN TRANSPORTER;

ADOLESCENT; ARTICLE; BORDERLINE STATE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEPRESSION; DISEASE CLASSIFICATION; FEMALE; HUMAN; HUMAN CELL; LIGAND BINDING; MALE; NEUROPSYCHOLOGICAL TEST; PATHOPHYSIOLOGY; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; RECEPTOR DENSITY; THROMBOCYTE;

ADOLESCENT; BORDERLINE PERSONALITY DISORDER; HEMATOLOGIC TESTS; HUMANS; LEUKOCYTES, MONONUCLEAR; PHENOTYPE; RECEPTORS, GABA-A; SEROTONIN;

EID: 67650957540     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2009.07.002     Document Type: Article

References (23)

1. Bradley R., Zittel Conklin C., and Westen D. The borderline personality diagnosis in adolescents: gender differences and subtypes. J. Child Psychol. Psychiatry 46 (2005) 1006-1019
2. Coccaro E.F., Kavoussi R.J., Sheline Y.I., Lish J.D., and Csernansky J.G. Impulsive aggression in personality disorder correlates with tritiated paroxetine binding in the platelet. Arch. Gen. Psychiatry 53 (1996) 531-536
3. Ferrarese C., Appollonio I., Frigo M., Perego M., Piolti R., Trabucchi M., and Frattola L. Decreased density of benzodiazepine receptors in lymphocytes of anxious patients: reversal after chronic diazepam treatment. Acta Psychiatr. Scand. 82 (1990) 169-173
4. Ferrarese C., Marzorati L., Perego M., Bianchi G., Cavarretta R., Pierpaoli C., Moretti G., and Frattola L. Effect of anticonvulsant drugs on peripheral benzodiazepine receptors of human lymphocytes. Neuropharmacology 34 (1995) 427-431
5. Johnson M.R., Marazziti D., Brawman-Mintzer O., Emmanuel N.P., Ware M.R., Morton W.A., Rossi A., Cassano G.B., and Lydiard R.B. Abnormal peripheral benzodiazepine receptor density associated with generalized social phobia. Biol. Psychiatry 43 (1998) 306-309
6. 3H-paroxetine to blood platelets in healthy volunteers: indications for a gender difference. Biol. Psychiatry 28 (1990) 509-517
7. Kovacs M. The Children's Depression Inventory (CDI). Psychopharmacol. Bull. 21 (1985) 995-998
8. 3H]-paroxetine binding to human platelets. J. Affect. Disord. 50 (1998) 11-15
9. Martial J., Paris J., Leyton M., Zweig-Frank H., Schwartz G., Teboul E., Thavundayil J., Larue S., Ng Ying Kin N.M., and Vasa van Nair N.P. Neuroendocrine study of serotonin function in female borderline personality disorder patients: a pilot study. Biol. Psychiatry 42 (1997) 737-739
10. 3H] imipramine binding in human platelet membranes. Eur. J. Pharmacol. 126 (1986) 155-158
11. 3H-imipramine to rat neuronal membranes. Psychopharmacology (Berl.) 89 (1986) 436-439
12. Nakamura K., Fukunishi I., Nakamoto Y., Iwahashi K., and Yoshii M. Peripheral-type benzodiazepine receptors on platelets are correlated with the degrees of anxiety in normal human subjects. Psychopharmacology (Berl.) 162 (2002) 301-303
13. Nakamura K., Yamada K., Iwayama Y., Toyota T., Furukawa A., Takimoto T., Terayama H., Iwahashi K., Takei N., Minabe Y., Sekine Y., Suzuki K., Iwata Y., Pillai A., Nakamoto Y., Ikeda K., Yoshii M., Fukunishi I., Yoshikawa T., and Mori N. Evidence that variation in the peripheral benzodiazepine receptor (PBR) gene influences susceptibility to panic disorder. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 141B (2006) 222-226
14. 3H] paroxetine binding in female patients with borderline personality disorder. Psychopharmacology (Berl.) 182 (2005) 447-451
15. Paris J., Zweig-Frank H., Kin N.M., Schwartz G., Steiger H., and Nair N.P. Neurobiological correlates of diagnosis and underlying traits in patients with borderline personality disorder compared with normal controls. Psychiatry Res. 121 (2004) 239-252
16. Patkar A.A., Gottheil E., Berrettini W.H., Hill K.P., Thornton C.C., and Weinstein S.P. Relationship between platelet serotonin uptake sites and measures of impulsivity, aggression, and craving among African-American cocaine abusers. Am. J. Addict. 12 (2003) 432-447
17. Rinne T., Westenberg H.G., den Boer J.A., and van den Brink W. Serotonergic blunting to meta-chlorophenylpiperazine (m-CPP) highly correlates with sustained childhood abuse in impulsive and autoaggressive female borderline patients. Biol. Psychiatry 47 (2000) 548-556
18. Ritsner M., Modai I., Gibel A., Leschiner S., Silver H., Tsinovoy G., Weizman A., and Gavish M. Decreased platelet peripheral-type benzodiazepine receptors in persistently violent schizophrenia patients. J. Psychiatr. Res. 37 (2003) 549-556
19. Shedler J., and Westen D. Refining the measurement of axis II: a Q-sort procedure for assessing personality pathology. Assessment 5 (1998) 333-353
20. Skodol A.E., Gunderson J.G., Pfohl B., Widiger T.A., Livesley W.J., and Siever L.J. The borderline diagnosis I: psychopathology, comorbidity, and personality structure. Biol. Psychiatry 51 (2002) 936-950
21. 3H] paroxetine binding related to impulsive suicide attempts and borderline personality disorder. Biol. Psychiatry 43 (1998) 740-746
22. Weizman R., and Gavish M. Molecular cellular and behavioral aspects of peripheral-type benzodiazepine receptors. Clin. Neuropharmacol. 16 (1993) 401-417
23. Westen D., and Shedler J. Revising and assessing axis II. Part II: toward an empirically based and clinically useful classification of personality disorders. Am. J. Psychiatry 156 (1999) 273-285